Biosimilars Gain Ground in Europe

May 7, 2012

May 7, 2012 | Thanks to enabling legislation and differing clinical trials requirements, Europe moves further ahead in biosimilar sales, with some US companies enjoying strong sales from biosimilars sold on the European market. Forbes